Buspirone Hydrochloride Compounded Oral Suspension
BRIEFING
Buspirone Hydrochloride Compounded Oral Suspension. Because there is no existing USP monograph for this compounded preparation, a new monograph based on a validated stability-indicating method for assessing stability is being proposed. The liquid chromatographic procedure in the Assay is based on analyses validated using Gemini C18 brand of column with L1 packing. The typical retention time for buspirone is about 23.2 min.
Please submit comments to CompoundingSL@usp.org.
(CMP: B. Groat)
Correspondence Number—C311348